Ron Cornell (@RonaldCornell) header
Ron Cornell (@RonaldCornell) profile picture
Seattle, WA
Joined February 2011
Photo by Ron Cornell (@RonaldCornell)Photo by Ron Cornell (@RonaldCornell)Photo by Ron Cornell (@RonaldCornell)Photo by Ron Cornell (@RonaldCornell)Photo by Ron Cornell (@RonaldCornell)Photo by Ron Cornell (@RonaldCornell)Photo by Ron Cornell (@RonaldCornell)Photo by Ron Cornell (@RonaldCornell)Photo by Ron Cornell (@RonaldCornell)Photo by Ron Cornell (@RonaldCornell)
Ron Cornell retweeted
Today we announced ongoing support from the U.S. Department of Health and Human Services (HHS) to accelerate the development of mRNA-based pandemic influenza vaccines. The award was made through the Rapid Response Partnership Vehicle (RRPV) Consortium with funding from the Biomedical Advanced Research and Development Authority (BARDA), part of the HHS Administration for Strategic Preparedness and Response (ASPR). Read more: investors.modernatx.com/news…
9
11
53
6,580
Ron Cornell retweeted
We announced today that our Phase 3 trial of mRNA-1283, an investigational next-generation COVID-19 vaccine, has met its primary efficacy endpoint.   Learn more: investors.modernatx.com/news…
24
4
124
37,584
Ron Cornell retweeted
"If the pediatrician or the OB would have said, hey, be careful of this - we might be in a different situation." Michelle and Joe Longo's third child was not tested for #cytomegalovirus (CMV) at birth and was discharged, despite exhibiting warning signs of the disease, including failing a newborn hearing screening. After persistent hearing problems, and seeking the opinion of multiple healthcare professionals, their son was diagnosed with congenital CMV at four months old. Learn more about their story: modernatx.com/en-US/media-ce… #CMVAwarenessMonth #StopCMV
6
24
4,449
📢@moderna_tx and @Merck announce 3-year data for mRNA-4157 (V940) in combination with KEYTRUDA(R) (pembrolizumab) in study of patients with high-risk stage III/IV melanoma. #FlagshipFounded
Moderna and @Merck today announced that mRNA-4157 (V940), an investigational individualized neoantigen therapy, in combination with KEYTRUDA, Merck’s anti-PD-1 therapy, demonstrated sustained improvement in recurrence-free survival and distant metastasis-free survival compared with KEYTRUDA alone in patients with high-risk stage III/IV melanoma following complete resection. These data are being presented for the first time today during a rapid oral abstract session at the 2024 @ASCO Annual Meeting (abstract hashtag#LBA9512). Learn more: investors.modernatx.com/news…
2
7
1,584
Ron Cornell retweeted
June is CMV Awareness Month! Did you know that #cytomegalovirus (CMV) remains the leading infectious cause of birth defects in the United States? Join us this month as we share the latest information about #CMV, including how to identify it, ways to help protect yourself and your family, patient stories, and research developments. Stay informed and help spread the word! Learn more at nowiknowcmv.com. #CMVAwarenessMonth #StopCMV #NowIKnowCMV
7
3
25
5,407
Ron Cornell retweeted
#ICYMI: Earlier today, we announced today that the U.S. FDA has approved mRESVIA® (Respiratory Syncytial Virus Vaccine). The approval was granted under a breakthrough therapy designation and marks the second approved #mRNA product from Moderna. Learn more: investors.modernatx.com/news…
22
60
70
41,678
Ron Cornell retweeted
A recent publication in @NatureComms reports that vaccinated individuals are less likely to experience #LongCOVID symptoms. Researchers analyzed data from over 323,000 people across the U.S., finding that those with two doses of a COVID #vaccine had a significantly lower rate of post-COVID conditions.
1
11
2
44
8,159
Ron Cornell retweeted
Four years on, #COVID19 remains a worse killer than Flu. A new US study published in @JAMA_current showed that last winter, patients hospitalized for COVID had a 35% higher risk of dying within 30 days than influenza patients. Learn more ⬇ bloomberg.com/news/articles/…
34
5
87
8,633
Ron Cornell retweeted
Long COVID is having a major impact on the productivity of health systems and the wider workforce. One recent estimate suggests that #LongCOVID may have cut labor supply in the European Union by more than 1 million full-time workers in 2022.
1
238
47
597
70,085
Ron Cornell retweeted
Your risk of #LongCOVID rises with each additional infection. A recent study has shown that by their third COVID infection, patients have a 40% chance of developing Long COVID symptoms. Learn more about the threat of Long COVID: modernatx.com/en-US/media-ce…
1
1,572
711
2,840
2,118,165
Ron Cornell retweeted
We’re excited to announce our ongoing collaboration with @OpenAI to co-innovate with a shared vision of AI’s immense potential in the future of business and healthcare. #AI and collaborations like this will be a key component to our ability to scale and maximize our impact on patients. Watch the video below and read our blog to learn more about our work with #OpenAI: modernatx.com/media-center/a…
63
38
312
148,706
Ron Cornell retweeted
Happy #EarthDay! 🌍💚 As a company working at the intersection of science, technology and health, we understand that the health of our planet is of great importance, and we are committed to doing our part to protect the environment not just today, but every day. Learn more about our commitment to sustainability by design: preview.modernatx.com/en-US/…
2
2
13
4,387
Ron Cornell retweeted
It is estimated that 65 million people globally, and as many as 16 million Americans may have symptoms of Long COVID. But what is it? What are its symptoms? Learn and help spread awareness about #LongCOVID, which can impact many different parts of the body ⬇

1
11
5
52
9,085
Ron Cornell retweeted
Long COVID has significant societal impacts on the healthcare system and on the economy - and as many as 4 million Americans are out of work because of it. According to a recent survey from the US CDC, #LongCOVID cases are surging, and a sudden rise in January has persisted into a second month. Read more: medscape.com/viewarticle/new…
8
1
24
6,538
Ron Cornell retweeted
Our CEO Stéphane Bancel recently joined @NasdaqExchange for an episode of Innovation Answered to discuss our vision, our platform, and answer questions about the future of #healthcare and technology innovation. Watch the full video in the link below ⬇
🩺 Health care reimagined: In this episode of Innovation Answered, leaders from #NasdaqListed @GEHealthCare, @Moderna_tx, and Dexcom discuss how the healthcare industry is at the cusp of a technological evolution, and how the @InvescoUS QQQ ETF is at the forefront of this evolution, empowering investors to become agents of innovation. ➡️ Watch the full episode here: nasdaq.com/campaign/sponsore…
4
1
21
10,909
Ron Cornell retweeted
It's all about #proteins. Your body makes >100,000 different kinds of proteins - from enzymes to antibodies - in a process called protein synthesis. And that's where #mRNA comes in. Learn more about how we are studying mRNA to see if one day it can teach our bodies to make its own #medicine ⬇
7
8
34
14,960
Ron Cornell retweeted
Being a creator is at the heart of who we are - and at Moderna, building and carving out new paths is celebrated and necessary for us to change the future of #medicine. In our latest video, meet members of our Automation Engineering team who are not just dreaming of a better future, but are actively building it, one innovation at a time. 🔬 🦾 modernatx.com/media-center/a…
2
2
22
3,956
Ron Cornell retweeted
Latino Americans are almost twice as likely to test positive for #COVID19 as White Americans - yet, less than 15% of Latino adults have received their latest COVID-19 shots. Read more from @MariaTeresa, CEO of @votolatino, on the importance of getting vaccinated against COVID-19: modernatx.com/en-US/media-ce…
4
2
12
4,316